Next 10 |
SOUTH ORANGE, NJ - ( NewMediaWire ) - April 23, 2024 - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today announced that it will be presenting at the Planet MicroCap Showcase: VEGA...
2024-03-07 19:51:07 ET Nephros, Inc. (NEPH) Q4 2023 Earnings Conference Call March 07, 2024, 04:30 PM ET Company Participants Kirin Smith - PCG Advisory Robert Banks - CEO Judy Krandel - CFO Conference Call Participants Nick Sherwood - Maxim Group ...
Full-Year Net Revenue of $14.2 Million and Fourth-Quarter Net Revenue of $3.3 Million SOUTH ORANGE, NJ, March 07, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and com...
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...
SOUTH ORANGE, NJ - ( NewMediaWire ) - February 29, 2024 - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its fourth quarter and fiscal year financial results on Thursd...
Nephros, Inc. (NASDAQ: NEPH) is one of today's top gainers. The company's shares have moved 0.5% on the day to $1.61. Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filt...
2023-12-13 10:00:34 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Motus GI, C4 T...
2023-12-12 14:09:20 ET More on Nephros Nephros Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Nephros Historical earnings data for Nephros Financial information for Nephros For further details see: Nephros CEO buys 18k sha...
2023-11-10 05:26:02 ET Nephros, Inc. (NEPH) Q3 2023 Earnings Conference Call November 08, 2023, 04:30 PM ET Company Participants Kirin Smith - PCG Advisory Robert Banks - CEO Judy Krandel - Chief Financial Officer Andy Astor - Advisor and Interim CFO Co...
2023-11-08 17:42:10 ET More on Nephros Seeking Alpha’s Quant Rating on Nephros Historical earnings data for Nephros Financial information for Nephros For further details see: Nephros GAAP EPS of -$0.02 beats by $0.05, revenue of $3.74M beats by $0.37M
News, Short Squeeze, Breakout and More Instantly...
SOUTH ORANGE, NJ - ( NewMediaWire ) - April 23, 2024 - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today announced that it will be presenting at the Planet MicroCap Showcase: VEGA...
Full-Year Net Revenue of $14.2 Million and Fourth-Quarter Net Revenue of $3.3 Million SOUTH ORANGE, NJ, March 07, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and com...
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...